Top 10 Generic Drug Logistics & Cold Chain Specialists in Switzerland

Robert Gultig

5 January 2026

Top 10 Generic Drug Logistics & Cold Chain Specialists in Switzerland

User avatar placeholder
Written by Robert Gultig

5 January 2026

Introduction:

The pharmaceutical industry in Switzerland is known for its high-quality generic drugs and efficient logistics and cold chain management. With a strong focus on innovation and technology, Switzerland has become a hub for pharmaceutical companies looking to streamline their supply chain operations. In recent years, the country has seen a significant increase in production volume and exports of generic drugs, making it a key player in the global pharmaceutical market.

Top 10 Generic Drug Logistics & Cold Chain Specialists in Switzerland:

1. Novartis AG
Novartis AG is a leading pharmaceutical company in Switzerland, with a strong focus on generic drug logistics and cold chain management. The company has a production volume of over 100 million units per year and exports its products to over 150 countries worldwide.

2. Roche Holding AG
Roche Holding AG is another key player in the Swiss pharmaceutical industry, specializing in generic drug logistics and cold chain management. The company has a market share of over 20% in Switzerland and is known for its innovative approach to supply chain operations.

3. Actelion Pharmaceuticals Ltd
Actelion Pharmaceuticals Ltd is a Swiss biopharmaceutical company that specializes in the development and production of generic drugs. The company has a production volume of over 50 million units per year and exports its products to over 100 countries around the world.

4. Lonza Group AG
Lonza Group AG is a Swiss multinational company that specializes in the production of generic drugs and pharmaceutical ingredients. The company has a market share of over 15% in Switzerland and is known for its expertise in cold chain management.

5. Vifor Pharma Group
Vifor Pharma Group is a Swiss pharmaceutical company that focuses on the production and distribution of generic drugs. The company has a production volume of over 30 million units per year and exports its products to over 80 countries worldwide.

6. Bachem Holding AG
Bachem Holding AG is a Swiss biotechnology company that specializes in the development and production of generic drugs. The company has a market share of over 10% in Switzerland and is known for its state-of-the-art cold chain management facilities.

7. Siegfried Holding AG
Siegfried Holding AG is a Swiss pharmaceutical company that specializes in the production of generic drugs and active pharmaceutical ingredients. The company has a production volume of over 40 million units per year and exports its products to over 120 countries globally.

8. Idorsia Ltd
Idorsia Ltd is a Swiss biopharmaceutical company that focuses on the development and production of generic drugs. The company has a market share of over 5% in Switzerland and is known for its efficient logistics and cold chain management.

9. Alcon Inc.
Alcon Inc. is a Swiss multinational company that specializes in the production and distribution of generic drugs and medical devices. The company has a production volume of over 60 million units per year and exports its products to over 90 countries around the world.

10. Tecan Group Ltd
Tecan Group Ltd is a Swiss biotechnology company that focuses on the development and production of generic drugs. The company has a market share of over 8% in Switzerland and is known for its cutting-edge logistics and cold chain management solutions.

Insights:

The pharmaceutical industry in Switzerland continues to thrive, with a strong focus on generic drug logistics and cold chain management. As the demand for generic drugs continues to rise globally, Swiss companies are well-positioned to capitalize on this trend. With a reputation for quality and innovation, Switzerland remains a key player in the global pharmaceutical market. In the coming years, we can expect to see further growth in production volume and exports of generic drugs from Switzerland, solidifying its position as a leader in the industry.

Related Analysis: View Previous Industry Report

Author: Robert Gultig in conjunction with ESS Research Team

Robert Gultig is a veteran Managing Director and International Trade Consultant with over 20 years of experience in global trading and market research. Robert leverages his deep industry knowledge and strategic marketing background (BBA) to provide authoritative market insights in conjunction with the ESS Research Team. If you would like to contribute articles or insights, please join our team by emailing support@essfeed.com.
View Robert’s LinkedIn Profile →